Literature DB >> 18950629

Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells.

Barbara Bosier1, Didier M Lambert, Emmanuel Hermans.   

Abstract

Agonists acting at the CB1 cannabinoid receptor in N1E-115 neuroblastoma cells were found to activate MAPK family members with reciprocal efficacies. Thus, HU 210 robustly increased phosphorylation of ERK1/2 whereas CP 55,940 was more effective in activating JNK. The use of selected kinase inhibitors confirmed that distinct signalling cascades were involved in these responses. This reciprocal control of MAPK activity was correlated with the observation that HU 210- and CP 55,940-mediated regulations of tyrosine hydroxylase gene expression were respectively impaired by MEK and JNK inhibitors. These data indicate that complex interactions of the CB1 receptor with intracellular signalling partners controlling MAPK activities may explain the apparent disparities in cellular responses to functional selective agonists.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950629     DOI: 10.1016/j.febslet.2008.10.022

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling.

Authors:  Barbara Bosier; Pierre J Doyen; Amandine Brolet; Giulio G Muccioli; Eman Ahmed; Nathalie Desmet; Emmanuel Hermans; Ronald Deumens
Journal:  Br J Pharmacol       Date:  2015-10-25       Impact factor: 8.739

2.  Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.

Authors:  Kwang H Ahn; Mariam M Mahmoud; Debra A Kendall
Journal:  J Biol Chem       Date:  2012-02-16       Impact factor: 5.157

Review 3.  CB1 and CB2 Receptor Pharmacology.

Authors:  Allyn C Howlett; Mary E Abood
Journal:  Adv Pharmacol       Date:  2017-06-12

4.  Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.

Authors:  Robert B Laprairie; Amina M Bagher; Melanie E M Kelly; Denis J Dupré; Eileen M Denovan-Wright
Journal:  J Biol Chem       Date:  2014-07-18       Impact factor: 5.157

5.  c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner.

Authors:  Angela N Henderson-Redmond; Caitlin M Nealon; Brian J Davis; Matthew B Yuill; Diana E Sepulveda; Henry L Blanton; Mary K Piscura; Michael L Zee; Chris P Haskins; David J Marcus; Ken Mackie; Josée Guindon; Daniel J Morgan
Journal:  Neuropharmacology       Date:  2019-11-20       Impact factor: 5.250

6.  Cell signaling dependence of rapid glucocorticoid-induced endocannabinoid synthesis in hypothalamic neuroendocrine cells.

Authors:  Christina Harris; Grant L Weiss; Shi Di; Jeffrey G Tasker
Journal:  Neurobiol Stress       Date:  2019-03-21

7.  Expression of endocannabinoid system components in human airway epithelial cells: impact of sex and chronic respiratory disease status.

Authors:  Matthew F Fantauzzi; Jennifer A Aguiar; Benjamin J-M Tremblay; Michael J Mansfield; Toyoshi Yanagihara; Abiram Chandiramohan; Spencer Revill; Min Hyung Ryu; Chris Carlsten; Kjetil Ask; Martin Stämpfli; Andrew C Doxey; Jeremy A Hirota
Journal:  ERJ Open Res       Date:  2020-12-14

Review 8.  The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction.

Authors:  Maria-Paz Viveros; Francisco-Javier Bermúdez-Silva; Ana-Belén Lopez-Rodriguez; Edward J Wagner
Journal:  Pharmaceuticals (Basel)       Date:  2011-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.